The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Breast cancer is one of the most-researched illnesses in the world. But some men suffering from the disease say they’re not able to benefit from new research and treatments.
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
Key Insights ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
23h
Missouri healthcare worker who had contact with a hospitalized patient infected with bird flu developed mild respiratory ...
The AstraZeneca PLC ADR AZN slumped 0.66% to $78.38 Friday, on what proved to be an all-around mixed trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback